07-13-2018 08:32 AM CET - Health & Medicine
Print

Cancer Biomarkers Market 2018 Top Profiled Companies are Becton Dickinson, Merck & Co., Agilent Technologies, Qiagen, Illumina, Affymetrix, Abbott Laboratories

Press release from: Data Bridge Market Research
Cancer Biomarkers Market
Cancer Biomarkers Market
Cancer Biomarkers Industry 2018 Global Market Research report covers a detailed study of the Global Cancer Biomarkers Market size, growth, share, trends, consumption, segments, application and Forecast 2024. This report gives you so valuable and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. It will help you to grow in the international market.

The Global Cancer Biomarkers Market has accounted to USD 10.9 billion in 2016, growing at a CAGR of 12.2% from 2017 to 2024, and is expected to reach USD 27.4 billion by 2024.

Download PDF sample copy of this research report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Cancer Biomarkers Market, By Tumor (Breast, Lung, Prostate), By Type (Protein Biomarker, Genetic Biomarkers), By Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), By Application (Diagnostic, Drug Discovery, Prognostic), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024

Top Competitors:

• Abbott Laboratories
• DiagnoCure Inc.
• Affymetrix, Inc.
• Illumina, Inc.
• Qiagen N.V.
• Roche Diagnostics Ltd.
• Agilent Technologies Inc.
• Quest Diagnostics Inc.
• Merck & Co. Inc.
• Hologic, Inc.
• Becton Dickinson and Company
• Among others.

To Avail 10% Discount On This Report Mail Us on:- sopan.gedam@databridgemarketresearch.com

Market Definition:

Cancer biomarkers are the molecules secreted by a tumor or a specific response of the human body indicating the presence of cancer. The biomarkers enable cancer detection at an early stage and facilitate high-speed noninvasive diagnosis using various genomics and proteomics tools. Cancer biomarkers are used for various applications such as cancer diagnostics, drug discovery and development, prognostics, personalized medicine, and surrogate endpoints. Over the years, cancer biomarkers have become an integral part of research in pharmaceutical and clinical trial companies, as they help to reduce the time and cost of the drug discovery and development process.

Factors such as rising prevalence of cancer, increasing government support for cancer biomarkers research, rising aging population, increasing use of biomarkers in the drug discovery and development process, and increasing use of biomarker tests for diagnosis purposes are fueling the growth of this market. However, poorly suited regulatory and reimbursement systems and high capital investments required for biomarker development and validation are the major factors restraining the growth of this market. Cancer biomarkers’ research and development is highly capital intensive; this is one of the key entry barriers for new players willing to enter the cancer biomarkers market. Majority of the biomarker development studies receive funding from government organizations or large pharmaceutical companies.

For More Details In-Depth Inquiry @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market Segmentation:

Based on type:

• Protein Biomarkers
• Genetic Biomarkers
• Other Biomarkers (Includes Viral, Cell, And Carbohydrate Biomarkers)

Based on cancer type:

Breast Cancer
Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• Other Cancers (Includes Melanoma, Leukemia, Gastric, Kidney, Liver, And Pancreatic Cancers).

By profiling technology:

• Omics Technologies
• Imaging Technologies
• Immunoassays
• Cytogenetics
• Bioinformatics

By Application:

• Diagnostic
• Drug Discovery
• Prognostic

Based on geography:

• North America
• Europe
• Asia-Pacific
• South America
• Rest Of The World

Key Questions Answered in Global Cancer Biomarkers Market Report:-

What will the market growth rate, Overview and Analysis by Type of Global Cancer Biomarkers Market in 2024?

What are the key factors driving, Analysis by Applications and Global Cancer Biomarkers Market?

What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Global Cancer Biomarkers Market?

What are Opportunities, Risk and Driving Force of Global Cancer Biomarkers Market?

What are the opportunities and threats faced by the vendors in Global Cancer Biomarkers Market?

What are the Global Cancer Biomarkers Market opportunities, market risk and market overview of the Market?

Download Detailed TOC @ databridgemarketresearch.com/toc/?dbmr=global-cancer-biom...

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1124001 • Views: 531
More releasesMore releases

You can edit or delete your press release here: